
G7 has been Trump-proofed to avoid trouble – here's how
The Canadian organisers of the G7 summit are taking no chances with Donald Trump this week, ditching the usual joint communiqué, padding the event with extra guests and reducing the amount of time when the world leaders sit around the same table.
It is the latest example of how global institutions are adapting to the return of an unpredictable and combative figure.
A diplomat in Washington DC, who has seen the schedule, said it included fewer plenary sessions of the full group and more one-on-one meetings
'There's a lot more of that than at other summits,' he said, 'which would make sense if you are worried about one person causing trouble.'
The last time Mr Trump attended a G7 summit in Canada he stormed off early, ripping up a joint communiqué and leaving a trail of withering tweets behind him.
His blanket use of trade tariffs has already set nerves on edge, according to Matthew P Goodman, who was deputy to the US G7 Sherpa during the Obama administration, one of the figures doing the heavy lifting on negotiations.
'Those two issues hang over this upcoming summit, and are going to make it very challenging for the host, Mark Carney, to manage this,' he said.
Canadian diplomats were buoyed by their new prime minister's performance at the White House recently, when he avoided the sort or tongue lashing delivered to some other world leaders.
But organisers are leaving nothing to chance.
World leaders are due to begin arriving on Sunday. They will fly into the international airport in Calgary from where they will helicopter to the picturesque setting of Kananaskis, deep in the Canadian Rockies.
Organisers have padded the number of attendees by inviting leaders from India, Brazil, Ukraine, Australia and Saudi Arabia (although Crown Prince Mohamed Bin Salman reportedly will not be attending).
Cyril Ramaphosa, the South African president, is coming. He knows better than most how Mr Trump can undo the best laid plans after being ambushed last month in the Oval Office and accused of allowing a 'white genocide' to unfold.
Mark Rutte, Nato secretary general, and António Guterres, the UN secretary general, are expected to attend.
There will also be a session on fentanyl smuggling, a cause particularly close to Mr Trump's heart.
The result is more breakaway bilateral meetings and fewer chances for Mr Trump to clog up the agenda.
Mr Goodman said: 'Any host of these forums, if they're smart, will minimise the time around the table. You need a certain amount of that, but you want to allow for a lot of time on the margins for bilateral conversations and meetings'
In 2018, Justin Trudeau, Canada's prime minister at the time, presided over a G7 summit where Mr Trump abruptly pulled the US out of a previously agreed communiqué, before blasting his host as 'dishonest and weak'.
He flew out of Canada early, apparently upset at the way Mr Trudeau had talked about Canadian tariffs on US exports.
It meant weeks of careful negotiations on easing trade tensions between the US and the European Union went up in smoke.
This time Mr Carney is preparing to issue a chairman's statement, according to The Toronto Star, avoiding the need for all the parties to agree on a joint position on awkward issues such as Ukraine or Israel's strikes on Iran.
'Our hope is that Mr Trump will join us in getting tougher on Russia and push through new sanctions,' said a senior diplomat from a G7 nation. 'But he could equally say, no, let's give them another two weeks and then there is no chance for agreement.'
That makes it almost impossible to make progress on a joint text ahead of the summit, he added.
'The problem is that no one knows what's on Trump's mind,' he said. 'Negotiating in the absence of that is not easy.'
The G7 summit is not the only high-stakes diplomacy this month. Nato leaders will assemble in The Hague next week, where defence spending will be top of the agenda.
Summit organisers there are preparing a one-page communiqué, The Telegraph revealed on Friday, designed to suit Mr Trump's attention span.
It will be almost entirely focused on one of the president's pet issues and the historic decision to more than double spending on defence by leaders to meet new capability targets for deterring a Russian invasion.
Mr Trump stormed out of his last Nato summit in the UK in 2019, abandoning plans for a press conference, after Mr Trudeau was caught on video apparently mocking the American president.
He was talking to Boris Johnson, the British prime minister, and Emmanuel Macron, the French president, discussing how Mr Trump liked to use photo opportunities to talk to the press.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Rhyl Journal
22 minutes ago
- Rhyl Journal
Canada agrees to ratify Britain's accession to major trans-Pacific trade pact
Ottawa will seek to introduce legislation to its parliament this autumn to formally approve Britain's entry to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP). The UK joined the bloc in 2024, but Canada is yet to ratify its accession – meaning Britain still faces pre-CPTPP trade barriers in exporting to the country. Following a bilateral meeting between the Prime Minister and his Canadian counterpart Mark Carney on Sunday, Downing Street said: 'Prime Minister Carney confirmed that Canada would ratify the UK's accession to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), seeking to introduce legislation to their parliament in the autumn. 'This will bring huge benefits to UK businesses by lowering tariffs when buying from and selling to Canada. 'They also agreed to set up a joint taskforce to turbocharge progress on other areas of mutual benefit, including technology and artificial intelligence – in support of shared growth and our national security. 'The taskforce will also look to make progress on the wider UK-Canada Free Trade Agreement.'


Telegraph
41 minutes ago
- Telegraph
NHS faces paying more for US drugs to avoid future Trump tariffs
Britain faces paying more for US drugs as part of a deal to avoid future tariffs from Donald Trump. The NHS will review drug pricing to take into account the 'concerns of the president', according to documents released after a trade agreement was signed earlier this year. White House sources said it expected the NHS to pay higher prices for American drugs in an attempt to boost the interests of corporate America. A Westminster source said: 'There's an understanding that we would look at the drug pricing issue in the concerns of the president.' The disclosure is likely to increase concerns about American interference in the British health service, which has long been regarded as a flashpoint in trade talks. It comes after Rachel Reeves announced a record £29 billion investment in the NHS in last week's spending review. The Chancellor's plans will drive spending on the health service up towards 50 per cent of all taxpayer expenditure by the mid-2030s, according to economists at the Resolution Foundation. The Telegraph has also learnt that under the terms of the trade deal with America, the UK has agreed to take fewer Chinese drugs, in a clause similar to the 'veto' given to Mr Trump over Chinese investment in Britain. The White House has asked the UK for assurances that steel and pharmaceutical products exported to the US do not originate in China, amid fears the deal could be used to 'circumvent' Mr Trump's punishing tariffs on Beijing. Mr Trump is enraged by how much more America pays for drugs compared with other countries and considers it to be the same issue as he has raised on defence spending. Just as the US president has heaped pressure on European nations to increase the GDP share they allocate to defence, he thinks they should spend more on drug development. An industry source said: 'The way we've been thinking about it and many in the administration have been thinking about it, it's more like the model in Nato, where countries contribute some share of their GDP.' Britain and the US 'intend to promptly negotiate significantly preferential treatment outcomes on pharmaceuticals and pharmaceutical ingredients', the trade deal reads. Pharmaceutical companies are also pushing for reductions in the revenue sales rebates they pay to the NHS under the voluntary scheme for branded medicines pricing, access and growth (VPAG) – a mechanism that the UK uses to make sure the NHS does not overpay. Non-US countries are 'free-riding' Last week, Albert Bourla, Pfizer's chief executive, said non-US countries were 'free-riding' and called for a US government-led push to make other nations increase their proportionate spend on innovative medicines. He said White House officials were discussing drug prices in trade negotiations with other countries. 'We represent in UK 0.3pc of their GDP per capita. That's how much they spend on medicine. So yes, they can increase prices,' Mr Bourla said. Industry sources said there was no indication yet on what the White House would consider to be a fair level of spending. Whatever the benchmark, Britain will face one of the biggest step-ups. UK expenditure on new innovative medicines is just 0.28pc of its GDP, roughly a third of America's proportionate spending of 0.78pc of its GDP. Even among other G7 nations, the UK is an anomaly. Germany spends 0.4pc of its GDP while Italy spends 0.5pc. Most large pharmaceutical companies generate between half and three quarters of their profits in the US, despite the fact that America typically makes up less than a fifth of their sales. This is because drug prices outside of the US can cost as little as 30pc of what Americans pay. Yet, pharmaceutical companies rely on higher US prices to fund drug research and development, which the rest of the world benefits from. A month ago, Mr Trump signed an executive order titled 'Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients', which hit out at 'global freeloading' on drug pricing. It stated that 'Americans should not be forced to subsidise low-cost prescription drugs and biologics in other developed countries, and face overcharges for the same products in the United States' and ordered his commerce secretary to 'consider all necessary action regarding the export of pharmaceutical drugs or precursor material that may be fuelling the global price discrimination'. Trung Huynh, the head of pharma analysis at UBS, said: 'The crux of this issue is Trump thinks that the US is subsidising the rest of the world with drug prices. 'The president has said he wants to equalise pricing between the US and ex-US. And the way he wants to do it is not necessarily to bring down US prices all the way to where ex-US prices are, but he wants to use trade and tariffs as a pressure point to get countries to increase their prices. 'If he can offset some of the price by increasing prices higher ex-US, then the prices in America don't have to go down so much.' Mr Huynh added: 'It's going to be very hard for him to do. Because [in the UK deal] it hinges on the NHS, which we know has got zero money.' Under VPAG, pharmaceutical companies hand back at least 23pc of their revenue from sales of branded medicines back to the NHS, worth £3bn in the past financial year. The industry is pushing for this clawback to be cut to 10pc, which would mean the NHS would have to spend around 1.54bn more on the same medicines on an annual basis. The Government has already committed to reviewing the scheme, a decision which is understood to pre-date US trade negotiations. A government spokesman said: 'This Government is clear that we will only ever sign trade agreements that align with the UK's national interests and to suggest otherwise would be misleading. 'The UK has well-established and effective mechanisms for managing the costs of medicines and has clear processes in place to mitigate risks to supply.'


North Wales Chronicle
an hour ago
- North Wales Chronicle
Israel and Iran trade strikes for a third day as hundreds reported dead
Planned talks on Iran's nuclear programme, which could provide an off-ramp, were called off. Israel's strikes have killed at least 406 people in Iran and wounded another 654, according to a human rights group that has long tracked the country, Washington-based Human Rights Activists. Iran's government has not offered overall casualty figures. The region braced for a protracted conflict after Israel's surprise bombardment of Iran's nuclear and military sites on Friday killed several top generals and nuclear scientists, and neither side showed any sign of backing down. Iran said Israel struck two oil refineries, raising the prospect of a broader assault on Iran's heavily sanctioned energy industry that could affect global markets. The Israeli military, in a social media post, warned Iranians to evacuate arms factories, signalling what could be a further widening of the campaign. At around noon local time, explosions were heard again in the Iranian capital Tehran. US President Donald Trump has expressed full support for Israel's actions while warning Iran that it can only avoid further destruction by agreeing to a new nuclear deal. Iranian foreign minister Abbas Araghchi said on Sunday that if the Israeli strikes on Iran stop, then 'our responses will also stop'. He said the United States 'is a partner in these attacks and must take responsibility'. New explosions echoed across Tehran and were reported elsewhere in the country early on Sunday, but there was no update to a death toll put out the day before by Iran's UN ambassador, who said 78 people had been killed and more than 320 wounded. In Israel, at least 10 people were killed in Iranian strikes overnight and into Sunday, according to Israel's Magen David Adom rescue service, bringing the country's total death toll to 13. The country's main international airport and airspace remained closed for a third day. Israeli strikes targeted Iran's Defence Ministry early on Sunday after hitting air defences, military bases and sites associated with its nuclear programme. The killing of several top generals and nuclear scientists in targeted strikes indicated that Israeli intelligence has penetrated Iran at the highest levels. In a sign that Iran expects the Israeli strikes to continue, state television reported that metro stations and mosques would be made available as bomb shelters for the public beginning on Sunday night. In Israel, at least six people, including a 10-year-old and a nine-year-old, were killed when a missile hit an apartment building in Bat Yam, near Tel Aviv. Daniel Hadad, a local police commander, said 180 people were wounded and seven are still missing. An Associated Press (AP) reporter saw streets lined with damaged and destroyed buildings, bombed out cars and shards of glass. Responders used a drone at points to look for survivors. Some people could be seen leaving the area with suitcases. Another four people, including a 13-year-old, were killed and 24 wounded when a missile struck a building in the Arab town of Tamra in northern Israel. A strike on the central city of Rehovot wounded 42. The Weizmann Institute of Science, an important centre for research in Rehovot, said 'there were a number of hits to buildings on the campus'. It said no-one was harmed. Israel has sophisticated multi-tiered air defences that are able to detect and intercept missiles fired at populated areas or key infrastructure, but officials acknowledge it is imperfect. World leaders made urgent calls to de-escalate. The attack on nuclear sites sets a 'dangerous precedent', China's foreign minister said. The region is already on edge as Israel seeks to annihilate Hamas, an Iranian ally, in the Gaza Strip, where the war is still raging after Hamas's October 7 2023 attack. Prime Minister Benjamin Netanyahu brushed off such calls, saying Israel's strikes so far are 'nothing compared to what they will feel under the sway of our forces in the coming days'. Israel, the sole though undeclared nuclear-armed state in the Middle East – said it launched the attack to prevent Iran from developing a nuclear weapon. The two countries have been regional adversaries for decades. Iran has always said its nuclear programme was peaceful, and the US and others have assessed it has not pursued a weapon since 2003. But it has enriched ever larger stockpiles of uranium to near weapons-grade levels in recent years and was believed to have been able to develop multiple weapons within months if it chose to do so. The UN's atomic watchdog censured Iran last week for not complying with its obligations. Mr Araghchi said Israel had targeted an oil refinery near Tehran and another in the country's Bushehr province on the Persian Gulf. He said Iran had also targeted 'economic' sites in Israel, without elaborating. Mr Araghchi was speaking to diplomats in his first public appearance since the initial Israeli strikes. Semi-official Iranian news agencies reported that an Israeli drone strike had caused a 'strong explosion' at an Iranian natural-gas processing plant. Israel's military did not immediately comment. The extent of damage at the South Pars natural gas field was not immediately clear. Such sites have air defence systems around them, which Israel has been targeting. An oil refinery was also damaged in the northern Israeli city of Haifa, according to the firm operating it. Bazan Group said pipelines and transmission lines between facilities were damaged, forcing some downstream facilities to be shut down. It said no-one was wounded. The Arab Gulf country of Oman, which has been mediating indirect talks between the US and Iran over Tehran's nuclear programme, said a sixth round planned for Sunday would not take place. 'We remain committed to talks and hope the Iranians will come to the table soon,' a senior US official said. Mr Araghchi said on Saturday that the nuclear talks were 'unjustifiable' after Israel's strikes, which he said were the 'result of the direct support by Washington'. In a post on his Truth Social account early on Sunday, Mr Trump reiterated that the US was not involved in the attacks on Iran and warned that any retaliation directed against it would bring an American response 'at levels never seen before'. 'However, we can easily get a deal done between Iran and Israel, and end this bloody conflict!!!' he wrote.